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Introduction
Tuberculosis (TB) remains one of the ten leading causes 
of mortality and is the second most common cause of infec-
tious diseases worldwide aft er HIV/AIDS. Th e problem of 
TB mortality decrease is of a planetary nature [3].  Accord-
ing to World Health Organization (WHO) the TB mortality 
rate decreased worldwide by 47% between 1990 and 2015. It 
is estimated that 49 million lives were saved by diagnosing 
and treating tuberculosis between 2000 and 2014 [8, 22].
Th e twentieth century has been marked by a revolution 
in the fi eld of fetal care with the emergence of the BCG vac-
cine and the fi rst and second-line anti-tuberculosis drugs. 
Th ese implementations in practice have allowed the spec-
tacular decrease in disease frequency in developed countries 
over a long period of time, creating the impression that the 
disease will be defeated [8, 23, 24]. However, since the 1990s, 
the worsening of the socio-economic situation, together with 
the imbalance in the health care system, has contributed to 
the worsening epidemiological indexes [25, 27, 28, 29].
Th e indicator of tuberculosis mortality is one of the most 
important demographic indicators. It characterizes not only 
the demographic well-being of the population but social and 
medical, as well [14, 16, 18]. Between 1990 and 2015 there 
was an essential decline in the 47% mortality rate worldwide 
[3, 10, 13, 24]. Th e index of tuberculosis morbidity aft er 1990 
in the Republic of Moldova has increased by 3-4 times, but 
in recent years it has stabilized and even decreased to 10 per 
100.000 population in 2015 and in 2016 constituted 11 per 
100.000 population [5, 13, 15]. In Chisinau, the mortality 
index registered a proportion of 6,8 per 100.000 thousand 
population with a decrease by approximately 50% between 
1990 and 2015 [9, 10, 11]. WHO for the years 2016-2035 
recommends a reduction in mortality by 90% compared to 
2015.  Th e National Program for TB Control in the Republic 
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Background: The main cause of death of tuberculosis patients is the progression of tuberculosis, but the presence of associated diseases decreases the 
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Conclusions: The most common concomitant diseases were: oncological, cardiovascular, hepatic cirrhosis and other causes. The number of deaths with 
the post-mortem tuberculosis diagnosis was decreasing; half of them occurred at home, ½ of the deceased were without a stable place of living.
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of Moldova for the years 2016-2020 predicts a mortality de-
crease by 35% [3].
Th e main cause of death of tuberculosis patients is the 
progression of tuberculosis, but the presence of associated 
diseases decreases the outcome of treatment of both the un-
derlying and the associated disease, and the latter is the cause 
of death [1, 6]. Th us, reducing the mortality of tuberculosis 
patients can be solved by increasing the therapeutic success 
rate of tuberculosis as well as associated diseases [19, 20, 26, 
28]. Post-mortem diagnosis of tuberculosis varies between 
2.0 and 6.0% of new cases of TB in diff erent countries [7, 
12, 17, 21]. Th e veracity of the mortality rate in tuberculosis, 
despite the high level of informality, largely depends on the 
expertise quality of the cause of death [2]. Of particular im-
portance in this context is the incorrect interpretation by the 
morphopathologist or forensic expert of the pathomorpho-
logical picture of tuberculosis, especially in post-mortem 
established diagnosis [23]. Th e level of post-mortem diag-
nosis has a decreasing trend lately. Errors in the diagnosis of 
tuberculosis are possible among the cases of post-mortem 
TB deaths in patients with acute forms of acute and epide-
miological tuberculosis, predominantly in people living with 
HIV [26]. Cases of death with post-mortem diagnosis of TB 
refl ect the level of detection organization, the quality of di-
agnosis of tuberculosis and occur more frequently in people 
without a stable place of living, diagnosis being determined 
by legal medicine or somatic stations [21].
Literature data on the causes of mortality of tuberculo-
sis patients through concomitant diseases are contradictory. 
Associated diseases are recorded in one third of tuberculosis 
patients [28]. According to some data presented in the year 
2014 tuberculosis patients on the record died due to other 
diseases and causes in 53.6% cases [28]. Th e rate of tuber-
culosis patients who died of HIV infection reached 23.4% 
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in the year 2010 [26]. Th e post-mortem diagnosis of TB in-
creases the mortality index in diff erent territories. 
Th us, in the mortality structure the causes of death are 
the result of multifactorial action on the human body, and 
among the main ones both the worsening of social-econom-
ic conditions and the level of organization of the service of 
pneumophtiziology are emphasized.
Th e purpose of the study was the comparative analysis of 
the cases of TB patients with other diseases and causes and 
the evaluation of post-mortem TB diagnosis among the new 
cases in Chisinau in three periods of time.
Material and methods
A selective and discursive retrospective study was carried 
out in 3 periods of time: period I (2001-2003) - Implemen-
tation of the DOTS strategy in Chisinau; period II (2007-
2009) characterized by the tense epidemiological situation, 
the high TB mortality indicator and the implementation of 
the “STOP TB” strategy; period III (2013-2015) character-
ized by a shift  to “End TB” strategy and a marked decrease in 
tuberculosis mortality.
For the purpose of the research, the cases of TB deceased 
patients in Chisinau with post-mortem diagnosis were stud-
ied in three periods of time: during the fi rst period in Chi-
sinau, 494 patients died of tuberculosis and the diagnosis of 
post-mortem TB was established in 99 (20± 1.8%) patients; 
in period II of the total 456 deaths of tuberculosis, 63 (13.8± 
1.6%) cases were detected post-mortem; in the third period 
of the total 225 deaths from tuberculosis, 29 (12.9±2.2%) cas-
es were detected post-mortem. Also, from the total number 
of deaths from tuberculosis in Chisinau in the reference pe-
riods were selected the cases of patients with pulmonary tu-
berculosis deceased of associated diseases and other causes: 
157 (25.3%) cases were selected in period I, in the period 
II – 110 (19.5%) cases and in period III – 112 (33.5%) cases.
Results and discussion
Analyzing the reference periods, we found that tubercu-
losis, associated diseases and other causes in the fi rst period 
led to 1/4 of the total deaths, in the second period there was 
a decrease in the number of deaths, and in the third period 
there was an approximately twice increase in the number of 
deaths.
Table 1
Distribution by gender
Sex
Period I 
(2001-2003)
n=157
Period II (2007-
2009) n=110
Period III 
(2013-2015) 
n=112
No M±m% No M±m% No M±m%
Men 121 77.1±3.4 79 71.8±4.3 89 79.5±3.8
Women 36 22.9±3.4 31 28.2±4.3 23 20.5±3.8
Note: no statistically significant difference between the periods has been 
established, p>0.05.
Analyzing the distribution of patients by gender, we es-
tablished the signifi cant predominance of male individuals 
versus female subjects in all periods studied (p<0.05). Th e 
male/female ratio was 3.4/1 in the fi rst period, 2.5/1 in the 
second period and 3.8/1 – in the third period. Diff erences 
between the studied periods were not signifi cant. Th e break-
down of cases by gender is shown in table 1.
Th e distribution of deaths by age showed that in the 0-4 
age group, deaths were recorded only in period I (1.3±0.8%) 
and in period II (0.9±0.9%). In the age group 15-24 years, 
the number of deaths was low: 3.2±1.4% of cases in the 1st 
period, 0.9±0.9% of cases in the 2nd period and 0.9±0.8% in 
the 3rd period, and in the age group 25-34 years: 10.8±2.4%, 
13.6±3.2% and 10.7±2.9% of cases, respectively. Deaths pre-
dominated in working-age patients (35-64 years) and the 
distribution was similar in the studied periods: 70.9% and 
69.6% respectively. In the 35-44 age group the number of 
deaths predominated signifi cantly in period I versus period 
II, for other age groups the diff erences between the reference 
periods were not signifi cant. In the group of patients aged 65 
years and over, the number of deaths increased insignifi cant-
ly: 14.7±2.8%; 13.7±3.2%; 18.8±18.7% of cases, respectively. 
Data are refl ected in table 2.
Table 2
Distribution of cases by age
Age
Period I 
(2001-2003) 
n=157
Period II 
(2007-2009) 
n=110
Period III 
(2013-2015) 
n=112
No M±m% No M±m% No M±m%
0-4 2 1.3±0.8 1 0.9±0.9 0 0
15-24 5 3.2±1.4 1 0.9±0.9 1 0.9±0.8
25-34 17 10.8±2.4 15 13.6±3.2 12 10.7±2.9
35-44 41 26.1±3.5* 17 15.5±3.4 23 20.5±3.8
45-54 36 22.9±3.3 36 32.7±4.4 31 27.7±4.2
55-64 33 21.0±3.2 25 22.7±3.9 24 21.4±3.8
65+ 23 14.7±2.8 15 13.7±3.2 21 18.8±18.7
Note: * – statistically significant difference between period I and II, p<0.05.
Studying the background of the deceased, we found 
the prevalence of urban people in all three studied periods 
(p<0.05): 86.6±2.7%, 75.5±4.1% and 54.4±4.4% of cases, re-
spectively. During the analyzed periods, a signifi cant increase 
in the number of deaths among persons in the suburbs was 
recorded in period II (24.5±4.1%) and III (33.0±4.4%) com-
pared to period I (13. 4±2.7% of cases), p<0.05. Th e number 
of people living in the urban area predominated signifi cantly 
in period III (12.5±3.1% of cases) compared to period II 
(4.5±1.9% of cases), p<0.05.
Analyzing the cases studied according to the methods of 
detecting the deceased, we established that the majority of 
patients in period I (98.7±0.8%) were detected by the pas-
sive method, by direct addressing. Th e dynamics shows a 
decrease in the direct addressing of patients to medical care: 
period II – 22.7±3.9% of cases and period III – 32.1±4.4% of 
cases, the diff erences compared to period I were of statistical 
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signifi cance (p<0.05). Th e activity of the family physician is 
manifested in periods II and III, by the detection of symp-
toms, which accounted for 1/3 of the cases during periods II 
and III. Th e detection of patients by the prophylactic control 
(active method) was not insignifi cant and decreasing: in the 
second period – 14.5±3.3% of cases and in the third period – 
8.9±2.6% of cases. Th e passive detection by addressing with 
the symptoms to other specialists was 1/5 of the deceased 
and the active detection was low: it is missing in period I; in 
period II – 8.1±2.6% of cases and in period III – 6.4±2.2% of 
cases. Th e data obtained are shown in table 3.
Table 3
Distribution of cases according to the detection method
Method
Period I 
(2001-2003) 
n=157
Period II 
(2007-2009) 
n=110
Period III 
(2013-2015) 
n=112
No M±m% No M±m% No M±m%
Direct addres-
sing
155 98.7±0.8 25 22.7±3.9* 36 32.1±4.4●
Symptomatic by 
family doctor
0 0 37 33.7±4.5* 36 32.1±4.4●
Prophylactic by 
family doctor
0 0 16 14.5±3.3* 10 8.9±2.6●
Symptomatic by 
another specia-
list
2 1.3±0.8 23 21.0±3.8* 23 20.5±3.8●
Prophylactic 
by another 
specialist
0 0 9 8.1±2.6* 7 6.4±2.2●
Note: * – statistically significant difference between period I and II, p<0.05;
Th e distribution of deaths by the type of case was the 
following: the new case was confi rmed in the majority 
(82.2±3.0%) of the deceased patients in period I, in period 
II it decreased to 51.8±4.7% of cases and in period III – to 
44.6±4.6% of cases. Relapses were recorded more frequent-
ly in periods II and III compared to period I: 28.2±4.2%, 
31.3±4.3%, 12.1±2.6%, respectively. Th e other types of cases 
(lost to follow up, therapeutic failure, chronic case) varied 
between 1.3-6.3% of cases. Th e distribution according to the 
recorded case is shown in table 4.
Table 4
Distribution by the type of case
Type of case
Period I 
(2001-2003) 
n=157
Period II 
(2007-2009) 
n=110
Period III 
(2013-2015) 
n=112
No M±m% No M±m% No M±m%
New case 129 82.2±3.0 57 51.8±4.7* 50 44.6±4.6●
Relapse 19 12.1±2.6 31 28.2±4.2* 35 31.3±4.3●
Lost to follow 
up
0 0 8 7.3±2.4* 16 14.3±3.3●
Therapeutic 
failure
0 0 11 10±2.8* 8 7.1±2.4●
Chronic case 0 0 2 1.8±1.2 3 2.7±1.5
Transferred 9 5.7±1.8 1 0.9±0.9* 0 0●
Note: * – statistically significant difference between period I and II, p<0.05; 
● – statistically significant difference between period I and III, p<0.05.
Of the clinical-radiological forms, infi ltrative pulmonary 
tuberculosis predominated signifi cantly in all three periods 
(p<0.05): 73.2±3.5% in period I, 70.9±4.3% in period II and 
88.4±3.0% of cases in period III, followed by disseminated 
form: 8.3±2.1%, 9.1±2.7%, 3.6±1.8%, respectively, and then 
fi brocystic tuberculosis: 5.1±1.7% of cases in period I and 
10±2.8% of cases in period II and was not recorded in period 
III. Intravascular extracellular tuberculosis as well as diff er-
ent organs varied between 0.3-0.8% of cases. Distribution 
according to the clinical forms of tuberculosis is presented 
in table 5. Intrathoracic and various organs vary between 
0.3-0.8% of cases.
Table 5
Distribution according to the clinical forms of 
tuberculosis
Form
 Period I 
(2001-2003) 
n=157
 Period II 
(2007-2009)
n=110
 Period III 
(2013-2015) 
n=112
No M±m% No M±m% No M±m%
Primary TB 
Complex
0 0 1 0.9±0.9 0 0
ITLN TB 2 1.±0.8 1 0.9±0.9 0 0
Peripheral TB 
adenopathy
1 0.6±0.6 0 0 0 0
Infiltrative TB 115 73.3±3.5● 78 70.9±4.3◊ 99 88.4±3.0
Nodular TB 2 1.3±0.8● 0 0◊ 7 6.3±2.3
Fibro-cavitary TB 8 5.1±1.7● 11 10±2.8◊ 0 0
Disseminated TB 13 8.3±2.1 10 9.1±2.7 4 3.6±1.8
TB pleurisy 10 6.4±1.9● 6 5.5±2.1◊ 0 0
TB of the bronchi 1 0.6±0.6 0 0 0 0
TB of the spine 2 1.3±0.8 0 0 2 1.7±1.3
TB of other bone 
locations
1 0.6±0.6 1 0.9±0.9 0 0
Renal TB (160) 1 0.6±0.6 0 0 0 0
TB of other 
organs 
1 0.6±0.6 0 0 0 0
TB  of CNS 0 0 2 1.8±1.2 0 0
Note: ITLN – intrathoracic lymph node, CNS – central nervous system, 
● – statistically significant difference between period I and III, p<0.05; 
◊ – statistically significant difference between IInd period and IIIrd 
period, p<0.05.
Respectively, the study of the results of the microscopic 
sputum examination at BAAR revealed a large number of de-
ceased persons with the negative result in all periods: 59.2%; 
47.3%; 55.4% of cases. Respectively, the results of MBT’s cul-
tural exams show even lower scores, increasing over the past 
periods: 17.2±3.0%, 30.0±4.3%, 43.7±4.6%. Absent dates on 
the bacteriological examination were evidenced in the Ist 
period at 53.4±3.9% of cases with a signifi cant decrease in 
the 2nd period (12.8±3.1%) and in period III (14.3±3.3% 
of cases). Th e results of MBT sensitivity tests on anti-tuber-
culosis drugs reported that the sensitivity of MBT to anti-
tuberculosis drugs decreased markedly in dynamics in the 
three periods: 55.5%, 39.4%, 22.4% respectively, and the 
MBT resistance to anti-tuberculosis drugs increased respec-
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tively in: 44.4%; 60.6% and 77.6% of cases. Th e results of the 
microbiological examination are presented in table 6. 
Table 6 
The results of the microbiological exam
MBT
Period I 
(2001-2003) 
n=157
Period II 
(2007-2009) 
n=110
Period III 
(2013-2015) 
n=112
No M±m% No M±m% No M±m%
Positive 27 17.2±3.0* 33 30±4.3◊ 49 43.7±4.6●
Negative 24 15.3±2.8* 35 31.8±4.4 42 37.5±4.5●
Missing data 91 57.9±3.9* 29 26.4±4.2 19 16.9±3.5●
It was not 
done
15 9.6±2.3 13 11.8±3.0◊ 2 1.8±1.3●
Note: * – statistically significant difference between the Ist period and the 
2nd period, p<0.05; ● – statistically significant difference between the Ist 
period and the 2nd period, p<0.05
Among cases with drug-resistant tuberculosis, multidrug 
resistance predominated in all periods studied with a higher 
frequency in the 3rd period. A similar number of patients 
was recorded with monoresistance, while the polyresistance 
was decreasing. Th e distribution of cases according to the 
spectrum of resistance is shown in table 7.
Table 7
The distribution of cases according 
to the spectrum of resistance
DST 
Results
Period I (2001-
2003) n=12
Period II (2007-
2009) n=20
Period III (2013-
2015) n=38
No M±m% No M±m% No M±m%
Mono 2 16.6±10.7 3 15±7.9 6 15.8±5.9
Poli 4 33.4±13.6● 3 15±7.9 2 5.3±3.6
MDR 6 50±14.4 14 70±10.2 30 78.9±6.6
Note: DST – drug susceptibility testing, ● – statistically significant 
difference between the 1st and the 3rd period, p<0.05.
Causes of death of tuberculosis patients by associated ill-
ness and other factors were broadly diverse and are reported 
in Table 8.Th e most common cause of death in all periods 
studied was oncological pathology (lung, head and neck, liv-
er, prostate), followed by cardiovascular pathology (ischemic 
cardiopathy) and decompensated liver cirrhosis that were 
more frequently confi rmed in period I, then more frequent 
community pneumonia in period II and chronic alcohol-
ism predominantly in period III. Vascular attack followed 
the most frequent occurrence in period I, followed by HIV/
AIDS and myocardial infarction more frequently in period 
II and diabetes.
Among other causes of death were: thromboembolism 
which was certifi ed only in the 2nd and the 3rd period (1.8% 
and 2.7%, respectively) and renal insuffi  ciency. Gastric ulcer 
was the cause of death only in period II (27%). Septicemia 
caused by other diseases was in 1.2%, 0.9%, 3.6% of cases, 
respectively. Other factors that caused death: road accidents 
(9.6%, 2.7%, 3.6%); suicide (0.6%, 1.8%, 0.9% of cases re-
spectively); thermal combustion (0.6%) and frostbite (4.5%) 
were recorded only in the 1st period, and CO2 poisoning – 
only in the 2nd period (0.9%). 
Table 8
Causes of death of tuberculosis patients by other diseases
The cause of
death
Period I 
(2001-2003) 
n=157
Period II 
(2007-2009) 
n=110
Period III 
(2013-2015) 
n=112
No M±m% No M±m% No M±m%
Oncological 
pathology
28 17.8±3.0 21 19.1±3.7 24 21.4±3.8
Pathology of 
the cardio-
vascular 
system
32 20.4±3.2* 5 4.5±1.9◊ 15 13.4±3,2
Decompen-
sated liver 
cirrhosis
27 17.2±3.0 15 9.6±3.2 10 8.9±2.6●
Community 
pneumonia
7 4.5±1.6 5 4.5±1.9◊ 15 13.4±3.2●
Chronic alco-
holism
7 4.5±1.6 10 9.1±2.7 10 8.9±2.6
Cerebral isch-
emic attack
13 8.3±2.1 7 6.4±2.3 6 5.4±2.1
HIV AIDS 6 3.8±1.5* 15 13.6±3.2◊ 3 2.7±1.5
Myocardial 
infarction
3 1.9±1.0* 9 8.2±2.6 5 4.5±1.9
Diabetes 7 4.5±1.6 5 4.5±1.9 3 2.7±1.5
Other causes 27 17.2±3.0 18 16.4±3.5 21 18.8±3.6
Note: * – statistically significant difference between period I and II, 
p<0.05.  ◊ – statistically significant difference between IInd period and 
IIIrd period, p<0.05.  The distribution of cases according to the place of 
death is reported in table 9.
Table 9
The place of death
The place of 
death
Period I (2001-
2003) n=157
Period II 
(2007-2009) 
n=110
Period III 
(2013-2015)
n=112
No M±m% No M±m% No M±m%
At home 92 58.6±3.9* 45 40.9±4.6 39 34.8±4.5●
Somatic 
Hospital
34 21.7±3.2 20 18.2±3.6 29 25.9±4.1
Specialized 
hospital
21 13.3±2.7* 35 31.8±4.4 26 23.2±3.9●
Other places 10 6.4±1.9 10 9.1±2.7 18 16.1±3.4●
Note: * – statistically significant difference between I period and II, p<0.05; 
● – statistically significant difference between I period and III, p<0.05.
Analyzing the place of death, we found that tuberculo-
sis patients died signifi cantly more frequently due to asso-
ciated diseases at home in the Ist period (p<0.05), the rate 
being decreased in the 2nd and 3rd periods. In the special-
ized tuberculosis hospitals, the index varied from 13.3±2.7% 
to 31.8±4.4%, and in the somatic one died every 5th patient 
from the 1st and 2nd periods and each fourth – in the third 
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period. Approximately 10% of patients died in other places.
In the reference years of the total post-mortem TB pa-
tients, 191 (16.3±1.1%) cases were diagnosed. Analyzing the 
number of deceased, diagnosed post-mortem in the studied 
periods, we established that in the dynamics the number of 
TB cases diagnosed post-mortem was decreasing. Data on 
the number of deaths with post-mortem tuberculosis from 
the total TB deaths are shown in table 10.
Table 10
 Distribution of TB cases established post-mortem 
according to the studied periods
Period of 
study
TB deaths
n = 1175
Post-mortem diagnosed TB 
No M ± m
I (2001-2003) 494 99 20,0 ± 1,8▪
II (2007-2009) 456 63 13,8 ± 1,6
III (2013-2014) 225 29 12,9 ± 2,2●
Note: ▪ – statistically significant difference between Period I and II, 
p<0.05; ● – statistically significant difference between Period I and III, 
p<0.05.
Comparing the results obtained in diff erent periods, we 
pointed out that the number of deaths of TB detected post-
mortem predominated in period I compared to period II 
and period III (p<0.05).
Analyzing the number of post-mortem deaths among 
new cases of TB we have identifi ed a continuous decrease in 
the number of deaths among the new cases: 2324 cases – in 
the fi rst period, 2126 cases – in the second period, and 1518 
cases – in the third period. Th e percentage of cases detected 
post-mortem among new cases in the 1st period amounted 
to 4.3%, in the 2nd period – 3% and in the 3rd period – 1.9%.
By distributing the cases of deceased by gender we estab-
lished the signifi cant predominance of male compared to fe-
male in all three time periods (p<0.05): in the 1st period – 85 
(85.9±3.5%) of men and 14 (14.1±3.5%) women, in the 2nd 
period – 47 (74.6±5.4%) and 16 (25.4±5.5%) women and 
in the 3rd period – 25 (86.2±6.4%) men and 4 (13.8±6.4%) 
women. Th e male / female ratio was 6: 1 in period I, 2.9:1 
in period II and 5.0:1 in period III. Diff erences between the 
studied periods were not signifi cant. Data are reported in 
table 11.
Table 11
Distribution of post-mortem TB cases by gender
Sex
Periods of study
I (2001-2003)
n = 99
II (2007-2009)
n = 63
III (2013-2015)
n =29
No M ± m No M ± m No M ± m
Men 85 85,9 ± 3,5▪ 47 74,6 ± 5,4▪ 25 86,2 ± 6,4▪
Women 14 14,1 ± 3,5 16 25,4 ± 5,5 4 13,8 ± 6,4
Note: ▪ – statistically significant difference between men and women, 
p<0.05.
Studying the age groups of the TB deaths detected post-
mortem we established that in the fi rst period the num-
ber of deaths predominated signifi cantly in the 51-60 age 
group – 42 (42.4±4.9%) cases, followed by the age group 41-
50 years – 26 (26.3±4.4%), then by age group 31-40 years 
– 14 (14.1±3.5%) cases, age group older than 60 years – 9 
(9.1±2.8%) cases, (p<0.05) and age group 21-30 years – 8 
cases (8.1±2.7%). Data are shown in table 12.
Table 12
Distribution of post-mortem TB deaths by age
Age groups
years
Periods of study
I (2001-2003)
n = 99
II (2007-2009)
n = 63
III (2013-2015)
n =29
No M ± m No M ± m No M ± m
21-30 8 8,1±2,7 2 3,2 ±2,2 5 17,2±7,0*
31-40 14 14,1 ± 3,5 12 19,1±4,9 5 17,2 ±7,0
41-50 26 26,3±4,4 19 30,1 ±5,7 5 17,5 ±7,0
51-60 42 42,4±4,9 19 30,1±5,7 5 17,5 ±7,0 ▪
≥60 9 9,1± 2,8 11 17,5±4,7 9 31,0 ±8,5▪
Note: ▪ – statistically significant difference between period I and period 
III, p<0.05; ● – statistically significant difference between period II and 
period III, p<0.05.
In the second period, 41-50 years old age group and the 
51-60 age group had a similar number of TB deaths – 19 
(30.1±5.7%) cases, which predominated insignifi cantly from 
the group aged 31-40 years – 12 (19.1±4.9%) cases and the 
age group older than 60 years – 11 (17.5 ±4.7%) cases and 
signifi cantly compared with the age group 21-30 years - 2 
(3.2±2.2%) cases, (p<0.05). In period III in the 21-30 years, 
31-40 years, 41-50 years and 51-60 years, 5 cases (17.5±7.0%) 
were recorded post-mortem, and in the age group older than 
60 years –  9 (31.0±8.5%) cases. Comparing the studied pe-
riods, we pointed out that the deaths in the age group 51-60 
predominated signifi cantly in period I compared to period 
III (p<0.05), in the age group over 60 years deaths predomi-
nated in period III compared to period I (p<0.05) and in the 
age group 21-30 deaths predominated in period III com-
pared to period II (p<0.05).
Table 13
TB deaths detected post-mortem according 
to the place of death
Periods of study
The place of death
Home Somatic hospitals Other places
No M ± m No M ± m No M ± m
I (2001-2003), n = 99 50 50,5±5,0 23 23,2±4,2 26 26,3±4,4
II (2007-2009), n = 63 28 44,4±6,2 9 14,3±4,4 26 41,3±6,2 ▪
III (2013-2015), n = 29 15 51,7±9,2 9 31,0±8,5 5 17,3±7,0 *
Note: * – statistically significant difference between period III and II, 
p<0.05; ▪ – statistically significant difference between period II and I, 
p<0.05.
Analyzing the place of death, we established that in 
all three periods approximately 1/2 of the patients died at 
home: in period I – 50 patients (50.5±5.0%), in period II – 
28 (44.4±6.2%) patients and in period III – 15 (51.7±9.2) 
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cases. In somatic hospitals died: in period I –23 patients 
(23.2±4.2%), in period II – 9 (14.3±4.4%) patients and in pe-
riod III – 9 (31.7±8.5%) cases. In other places, died: in the 
1st and 2nd periods – 26 patients (26.2±4.4% and 41.3±6.2% 
respectively) and in the 3rd period – 5 (17.3±7.0 %) cases, 
signifi cantly less compared to period II, (p<0.05). Data are 
presented in table 13. 
By evaluating the belonging to socially vulnerable groups, 
we established that among the cases of deaths with post-mor-
tem TB 44 (44.4±4.9%) patients in period I, 26 (41.3±6.2%) 
patients in period II and 9 (31.0±8.6%) patients in period III 
were without stable living space (homeless). Th e distribution 
of TB deaths detected post-mortem according to the pre-
sence/absence of the place of residence is shown in fi gure 1.
Fig. 1.  Distribution of TB deaths detected post-mortem.
Th us, during the studied periods, we have determined 
the decrease of the number of patients’ living places. Th is 
was done with the help of the non-governmental organiza-
tion “AFI” through the early active detection of tuberculosis 
and the treatment in both phases in stationary conditions.
Conclusions
Th e number of deaths of pulmonary tuberculosis due to 
concomitant illnesses and other causes in the reference peri-
ods was rising as the number of deceased persons in suburbs 
increased. Male subjects predominated compared to females 
both in the group of deaths from pulmonary tuberculosis 
due to concomitant diseases and in post-mortem diagnosis 
of tuberculosis. Detection of deaths of tuberculosis patients 
by progression of associated diseases was predominantly re-
alized by the passive method, with the predominance of pul-
monary tuberculosis, with a high rate of infi ltrative form in 
the tuberculosis process destruction phase in approximately 
half of cases.
Sputum microscopy at BAAR was negative in half of the 
deceased, during the last two periods the number of bacte-
riological examinations increased; the increase of MBT re-
sistance to anti-tuberculosis drugs took place on the account 
of MDR resistance. Associated diseases that more frequently 
contributed to the death of the tuberculosis patient are: can-
cer of various organs, ischemic heart disease, cirrhosis, com-
munity pneumonia, alcoholism and other causes.
Th e number of deaths with post-mortem diagnosis of 
tuberculosis and their share among new cases has been de-
creasing in the studied periods. Half of the deaths with the 
post-mortem diagnosis of tuberculosis occurred at home, 
their number being stable in all studied periods, the number 
of deaths in the somatic stations increased during the third 
period, and the deaths in other places doubled during the 
period II and have been decreasing in the third period.
Approximately 1/2 of deceased individuals with post-
mortem diagnosis of tuberculosis had no place of stable liv-
ing, but there is a downward trend in the number of home-
less deceased in the 3rd period.
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